Skip to content

A follow-up study of long-term prognosis in patients with severe novel coronavirus pneumonia (COVID-19)

A follow-up study of long-term prognosis in patients with severe novel coronavirus pneumonia (COVID-19)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000034781
Enrollment
Unknown
Registered
2020-07-18
Start date
2020-06-16
Completion date
Unknown
Last updated
2020-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

severe and critical COVID-19 cohorts:None

Sponsors

Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients hospitalized for severe and critical COVID-19 (the seventh edition of coVID-19 Guidelines) from January to April 2020 and discharged alive. 1. Older than 18 years; 2. Sign the informed consent; 3. Patients diagnosed with severe and critical COVID-19 during hospitalization and discharged alive; 4. Complete clinical data during hospitalization.

Exclusion criteria

Exclusion criteria: Patients younger than 18 years old, who refuse to sign the informed consent form, who are too old to move or take care of themselves, or who cannot get to Jinyintan Hospital for examination.

Design outcomes

Primary

MeasureTime frame
Blood routine, liver and kidney function, random blood glucose testing and glycosylated hemoglobin, chest HRCT, lung function, echocardiography (assessment of right heart function only in critically ill patients), lower extremity intravenous ultrasound, pulmonary gas magnetic resonance imaging and cranial MRI;

Countries

China

Contacts

Public ContactHuang ChaoLin, Shang You, Zhou Xi

Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital)

88071718@qq.com+86 15307173189

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026